Health Catalyst to Participate in Upcoming Investor Conference
Healthcare analytics firm Health Catalyst announced it will attend a forthcoming investor meeting to discuss data monetization strategies and industry trends.
13 stories found
Healthcare analytics firm Health Catalyst announced it will attend a forthcoming investor meeting to discuss data monetization strategies and industry trends.
Several companies, including Gray Media, Kingstone Companies, and Johnson Outdoors, have released their Q2 earnings reports and provided financial outlooks. These reports detail their performance, revenue, and future projections.
Embecta's CEO is focusing on GLP-1 drugs and diversification through Owen Mumford to reset the company's strategy in the U.S. market.
Embecta released highlights from its second-quarter earnings call, detailing financial outcomes and business updates for the quarter.
Embecta has announced its intention to acquire Owen Mumford in a deal valued at up to £150 million, expanding its portfolio in the medical device sector.
Embecta projects an adjusted EPS of $1.80-$1.90 for fiscal year 2026 and has raised its adjusted operating margin forecast to 23.5%-24%.

Airbnb's shares surged 15% after the company reported strong earnings that beat expectations and announced plans to significantly increase investment in AI. The company also raised its revenue forecast, partly driven by demand from the World Cup.
Embecta Corp. has provided a summary of its Q2 2026 earnings call. The report outlines the company's financial results and key highlights from the quarter.
Embecta has announced a substantial reduction in its quarterly dividend, slashing it from $0.15 to $0.01 per share.
Wendy's, Banc of California, and Embecta have each declared their respective quarterly dividends to shareholders.
Embecta (EMBC) has experienced a significant target cut from analysts, attributed to a weakening sentiment in the medtech sector.
Leonardo DRS reported strong first-quarter results, leading the company to raise its financial outlook for fiscal year 2026. In contrast, Embecta missed its top-line and bottom-line estimates, consequently lowering its FY26 outlook.
These articles examine healthcare companies like Spok Holdings and Embecta to determine their standing among the top dividend-paying stocks in the sector. The analysis focuses on identifying high-yield investment opportunities within healthcare.